


Anti-RET Recombinant Antibody Products

Anti-RET Products
- Recombinant Anti-RET Antibody (MOB-844)
-
- Derivation: Mouse
- Type: IgG
- Application: ELISA, IP, FuncS
- Recombinant Human Anti-RET Antibody (MHH-844)
-
- Derivation: Human
- Type: IgG
- Application: WB, Neut, FuncS
- Mouse Anti-RET Recombinant Antibody (clone 8D10C9) (VS3-XY1369)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB
-
- Species Reactivity: Human, Mouse, Rat
- Type: Rabbit IgG
- Application: WB, IF, IHC, IP, FC
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, FC
- Rabbit Anti-RET Recombinant Antibody (VS3-CJ479) (VS3-CJ479)
-
- Species Reactivity: Human, Mouse, Rat
- Type: Rabbit IgG
- Application: WB, ICC, IF, IHC, IP, FC
- Mouse Anti-RET Recombinant Antibody (clone 6E4C4) (VS3-XY1368)
-
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: ELISA, WB
- Anti-Human RET Recombinant Antibody (Y078) (TAB-066MZ)
-
- Type: Human antibody
- Application: Cyt, IHC, FC
- Anti-Human RET Recombinant Antibody scFv Fragment (Y078) (TAB-066MZ-S(P))
-
- Type: Human antibody
- Application: IHC
- Anti-Human RET Recombinant Antibody Fab Fragment (Y078) (TAB-066MZ-F(E))
-
- Type: Human antibody
- Application: IHC
-
- Species Reactivity: Human
- Application: WB
- Recombinant Human Anti-RET Antibody Fab Fragment (MHH-844-F(E))
-
- Derivation: Human
- Type: Fab
- Application: ELISA, WB, FC, FuncS
- Recombinant Human Anti-RET Antibody scFv Fragment (MHH-844-S(P))
-
- Derivation: Human
- Type: scFv
- Application: ELISA, WB, FuncS
- Recombinant Anti-RET Antibody Fab Fragment (MOB-844-F(E))
-
- Derivation: Mouse
- Type: Fab
- Application: RIA, WB, FuncS
- Recombinant Anti-RET Antibody scFv Fragment (MOB-844-S(P))
-
- Derivation: Mouse
- Type: scFv
- Application: FC, Neut, Funcs
-
- Antibody Host: Human
- Antibody Reactivity: Human
-
- Species Reactivity: Human, Mouse
- Type: Rabbit IgG
- Application: WB, ICC, IF, IHC-P, IP, FC
- Mouse Anti-RET Monoclonal Antibody (VS7-0425-WR777) (VS7-0425-WR777)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA
-
- Target: RET
- Host Animal: Human
- Application: Cyt, ELISA, FC, Cell-uptake
- Anti-Mouse RET Immunohistochemistry Kit (VS-0525-XY6083)
-
- Species Reactivity: Mouse
- Target: RET
- Application: IHC
- Chicken Anti-Human RET Polyclonal IgY (BRD-1148MZ)
-
- Species Reactivity: Human
- Type: Chicken antibody
- Application: WB, ICC
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: IgG
- Application: WB, IHC, ICC, IP, FC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs offers a series of high-quality anti-RET recombinant antibodies to advance global customers’ research projects. Based on our cutting-edge antibody engineering platform, these antibodies exhibit excellent sensitivity and excellent specificity, making them the optimal selection for diverse research application.
RET: A Versatile Immunotherapeutic Target
The RET (REarranged during Transfection) proto-oncogene is constitutively activated through structural reconfiguration, wherein its 3' tyrosine kinase domain undergoes genetic recombination with the 5' regions of partner genes encoding dimerization motifs, such as coiled-coil domains. Such oncogenic fusions have been identified across multiple malignancies, including carcinomas of the thyroid, lung, colorectal tissue, breast, and salivary glands. Functional genetic analyses reveal RET's indispensable contributions to enteric nervous system formation, renal organogenesis, and germ cell maturation. Ongoing investigations into RET-mediated signaling pathways continue to yield critical insights, bridging molecular oncology with fundamental studies of neural development and tissue morphogenesis.
Alternative Names
RET proto-oncogene; ret proto-oncogene; Ret; PTC; RET51; RET9; c-Ret; CDHF12; CDHR16; HSCR1; MEN2A; MEN2B; MTC1; RET-ELE1.
Background
This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis.
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins
Intracellular, Membrane (different isoforms)
Group enriched (Horizontal cells, Ionocytes, Skeletal myocytes)
Not detected in immune cells
Cell line enhanced (MCF7, NB-4, SH-SY5Y, THP-1)
Phosphorylated form interacts with the PBT domain of DOK2, DOK4 and DOK5 (By similarity). The phosphorylated form interacts with PLCG1 and GRB7 (By similarity). Interacts (not phosphorylated) with PTK2/FAK1 (via FERM domain) (PubMed:21454698). Extracellular cell-membrane anchored RET cadherin fragments form complex in neurons with reduced trophic status, preferentially at the contact sites between somas (PubMed:21357690). Interacts with AIP in the pituitary gland; this interaction prevents the formation of the AIP-survivin complex (PubMed:19366855). Binds to ARTN (By similarity). Interacts (inactive) with CBLC and CD2AP; dissociates upon activation by GDNF which increases CBLC:CD2AP interaction (PubMed:18753381). Interacts (via the extracellular domain) with GFRAL (via the extracellular domain); the interaction mediates cellular signaling upon interaction of GFRAL with its ligand GDF15 (PubMed:28953886, 28846097, 28846099). Interaction with GFRAL requires previous GDF15-binding to GFRAL (PubMed:28846097, 28846099). Interacts with GFRA1; in the presence of SORL1, the GFRA1/RET complex is targeted to endosomes (PubMed:23333276). Interacts with GDNF (PubMed:21994944).
Kinase, Transferase, Tyrosine-protein kinase
Anti-RET rAb Products
Creative Biolabs delivers engineered recombinant antibodies targeting RET, meticulously optimized for high-affinity binding and molecular specificity. These adaptable formats serve multifaceted applications spanning immunological studies, oncological investigations, and drug development pipelines. Production workflows incorporate rigorous quality control systems, reinforced by multidimensional validation protocols encompassing epitope mapping and functional characterization. By synthesizing molecular engineering innovations with standardized quality frameworks, the platform generates antibody reagents with enhanced target discrimination, binding stability, and methodological reproducibility—ensuring experimental reproducibility across fundamental and translational research applications.
Table 1. Featured anti-RET recombinant antibody products at Creative Biolabs.
Cat. No. | Product Name | Target Species | Host Species | Applications |
ZG-0546U | Rabbit Anti-RET Recombinant Antibody (clone 8D12) (CAT#: ZG-0546U) | Human | Rabbit IgG | ELISA, FC |
ZG-066R | Mouse Anti-RET Recombinant Antibody (ZG-066R) | Human | Mouse IgG | WB, ELISA |
ZG-065R | Mouse Anti-RET Recombinant Antibody (ZG-065R) | Human | Mouse IgG | WB, ELISA |
VS3-XY1369 | Mouse Anti-RET Recombinant Antibody (clone 8D10C9) | Human | Mouse IgG1 | WB, ELISA |
TAB-066MZ | Anti-Human RET Recombinant Antibody (Y078) | Human | Human antibody | Cyt, IHC, FC |
Creative Quality Control
Creative Biolabs employs multistage quality assurance protocols to engineer anti-RET recombinant antibodies with high specificity and robust binding kinetics. Rigorous analytical validation ensures consistent functional performance of these biologics across diverse experimental systems, supported by standardized testing methodologies to confirm reproducibility in research applications.
Fig.1 FC analysis of anti-RET antibody
(Cat# ZG-0546U, Creative Biolabs).
Fig.2 WB analysis of anti-RET antibody
(Cat# ZG-066R, Creative Biolabs).
Fig.3 WB analysis of anti-RET antibody
(Cat# ZG-065R, Creative Biolabs).
Customer Reviews

Mouse Anti-RET Recombinant Antibody (clone 8D10C9) (VS3-XY1369)

Mouse Anti-RET Recombinant Antibody (ZG-065R) (ZG-065R)

Rabbit Anti-RET Recombinant Antibody (VS3-CJ479) (VS3-CJ479)
rAb Production
Creative Biolabs provides a reliable global supply of high-quality anti-RET recombinant antibodies, meticulously developed through cutting-edge recombinant technology for research applications.
Featured Anti-RET Recombinant Antibody Production Platforms
Fig.4 Milligram-scale anti-RET recombinant antibody production.
Fig.5 Gram-scale anti-RET recombinant antibody production.
rAb Modalities
Creative Biolabs offers high-quality, customisable anti-RET recombinant antibodies tailored to meet specific research needs. These antibodies are offered in various forms and are meticulously tailored to meet the specific needs of local, national, and global research communities.
Fig.6 Full-length anti-RET recombinant antibody production and modalities.
RET-Targeted Drug Information
Table 2. Public drug targeting RET.
Company | Research phase | Classification | Condition |
Yuhan (Originator) | Preclinical |
Fusion Proteins Growth Factors Polypeptides, from 41 AA |
Obesity |
Henan Institute of Science Technology (Originator) | Preclinical |
Polypeptides, from 41 AA Recombinant proteins |
Parkinson's disease |
Institut Gustave Roussy (Originator) Universite Paris - Sud 11 (Originator) |
Preclinical | Small Interfering RNA (SiRNAs) | Endocrine cancer |
Universitaet Rostock (Originator) | Preclinical |
Adenoviral Vectors Gene Therapy |
Cancer, thyroid, medullary |
Shaoxing University (Originator) | Biological Testing |
Pegylated Drugs Prodrugs |
Cancer Infection, bacterial Inflammatory disorders |
Regeneron (Originator) | Biological Testing |
Cancer Immunotherapy Human Monoclonal Antibodies |
Cancer |
Zhejiang University (Originator) | Biological Testing |
Camptothecins Nanoparticles Polymer-Drug Conjugates |
Cancer |
Hangzhou Cancer Hospital (Originator) | Biological Testing |
Polymer-Drug Conjugates Vitamin E Analogues |
Cancer |
Nektar Therapeutics (Originator) | Biological Testing | Polymer-Drug Conjugates | Cancer |
(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)
With extensive expertise in the antibody development sector, Creative Biolabs boasts years of exceptional experience in both antibody engineering and production. The performance of these antibodies is outstanding across a range of research applications. If you have an interest in our RET recombinant antibodies, we invite you to reach out to us for exclusive pricing information.